Damien JOLLY
Reims, France
NCT Number: NCT04356378
Infection with coronavirus SARS-CoV2 (COVID-19 disease) is unique with its speed of propagation, structural medical reorganizations and length of stay in intensive care needed, diversity of the affected population (in particular between young persons or fragile subjects), and impact on physical and mental health generated by confinement of populations.
Fatigue is a major component of COVID-19. Global muscular weakness is related to immobility, inflammation, corticosteroids treatment, hypoxemia due to pulmonary and/or cardiac infectious attacks and undernutrition suggests major physical functional repercussions. Thus, patients affected by COVID-19 with acute hospital management require sometimes complex rehabilitation management.
Retrospective studies on physical functional capacities in patients infected with SARS CoV1 showed long term physical activity limitations.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Reims, France
The aim of this study is to study factors associated with physical functional limitations in daily living in patients SARS-CoV2 infected and hospitalized in the acute phase then requiring rehabilitation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Data record
Time frame: 12 months
Physical functional limitations evaluated using 'sit to stand' test. The patient, seated in a chair without armrest, his arms crossed over his shoulders, should get up and sit down without help of the upper limbs as many times as possible in one minute.
CHU de Reims
Other
Long Term Physical Functional Performance in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation: a Multicentric Observational Study
Acronym: CAPACoV19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04615429
Acute Respiratory Distress Syndrome, COVID-19 Pneumonia
Majadahonda, Madrid, Spain
View Trial DetailsNCT04478071
Acute Respiratory Distress Syndrome, COVID-19
Houston, Texas, United States
View Trial DetailsNCT04619368
COVID-19, Coronaviridae Infections
Toulouse, France
View Trial DetailsNCT04384445
Acute Respiratory Distress Syndrome, COVID-19
New York, United States
View Trial Details